1. Diabetes enhances hepatocarcinogenesis in noncirrhotic, interferon-treated hepatitis C Patients
- Author
-
Kawamura, Yusuke, Arase, Yasuji, Ikeda, Kenji, Hosaka, Tetsuya, Kobayashi, Masahiro, Saitoh, Satoshi, Yatsuji, Hiromi, Sezaki, Hitomi, Akuta, Norio, Suzuki, Fumitaka, Suzuki, Yoshiyuki, Kumada, Hiromitsu, and Hirakawa, Miharu
- Subjects
Hepatoma -- Risk factors ,Hepatoma -- Research ,Diabetes -- Complications and side effects ,Diabetes -- Research ,Hepatitis C virus -- Care and treatment ,Hepatitis C virus -- Research ,Health ,Health care industry - Abstract
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.amjmed.2010.05.013 Byline: Yusuke Kawamura, Yasuji Arase, Kenji Ikeda, Miharu Hirakawa, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saitoh, Hiromi Yatsuji, Hitomi Sezaki, Norio Akuta, Fumitaka Suzuki, Yoshiyuki Suzuki, Hiromitsu Kumada Keywords: Diabetes; Hepatocellular carcinoma; Interferon; Sustained virologic response Abstract: This retrospective cohort study assessed the impact of diabetes mellitus on hepatocarcinogenesis and determined the predictors of hepatocarcinogenesis in noncirrhotic, interferon-treated patients with hepatitis C virus infection. Author Affiliation: Department of Hepatology, Toranomon Hospital, Tokyo, Japan Article Note: (footnote) Funding: Okinaka Memorial Institute for Medical Research and Japanese Ministry of Health, Labour and Welfare., Conflict of Interest: None of the authors have any conflicts of interest associated with the work presented in this manuscript., Authorship: All authors had access to the data and played a role in writing this manuscript.
- Published
- 2010